← Leaderboards
Meryl S Leboff
Brigham And Women'S Hospital
$9,246,227
Attributed
$10,602,037
Total exposure
23
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$10,602,037 · 23
By mechanism
R01$10,210,325 · 4
P60$303,601 · 1
M01$88,111 · 18
Top collaborators
- Carolyn Janet Crandall4 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Charles S Fuchs$37,354,862
- Daniel R Kuritzkes$313,891,104
- Kenneth H Mayer$64,411,257
- Julie E Buring$63,823,301
- Daniel Hal Solomon$26,002,677
Others in their field
Top investigators on “Bone Density”
- Richard A Gibbs · Baylor College Of Medicine$49,965,365
- Steven R Cummings · University Of California San Francisco$45,557,505
- Peter J. Snyder · University Of Pennsylvania$37,887,894
- Douglas P. Kiel · Hebrew Rehabilitation Center For Aged$31,628,442
- Eric S. Orwoll · Oregon Health And Science University$27,305,691
- Hong-Wen Deng · Father Flanagan'S Boys'Home$24,036,296
Research focus
Bone DensityClinical ResearchWomanHuman SubjectOsteoporosisUnited States National Institutes Of HealthCohortResourcesRandomizedBoneParticipantHip FracturesFractureElderlyPlacebosRaceAncillary StudySupplementationAgedBody Mass IndexVitamin DBone HealthHuman Therapy EvaluationFemale
Grant awards (56)
COcoa Supplement and Multivitamins Outcomes Study (COSMOS): Effects on Falls and Physical Performance$670,395
R01 · FY2024 · AG · contact PI
COcoa Supplement and Multivitamins Outcomes Study (COSMOS): Effects on Falls and Physical Performance$676,919
R01 · FY2023 · AG · contact PI
COcoa Supplement and Multivitamins Outcomes Study (COSMOS): Effects on Falls and Physical Performance$675,959
R01 · FY2022 · AG · contact PI
VITamin D and OmegA-3 TriaL (VITAL): Interrelationship of Vitamin D and Vitamin K on Bone$553,289
R01 · FY2022 · AR · contact PI
VITamin D OmegA-3 TriaL (VITAL): Fractures, Vitamin D and Genetic Markers$536,849
R01 · FY2022 · AR · contact PI
COcoa Supplement and Multivitamins Outcomes Study (COSMOS): Effects on Falls and Physical Performance$688,348
R01 · FY2021 · AG · contact PI
VITamin D and OmegA-3 TriaL (VITAL): Interrelationship of Vitamin D and Vitamin K on Bone$656,827
R01 · FY2021 · AR · contact PI
VITamin D OmegA-3 TriaL (VITAL): Fractures, Vitamin D and Genetic Markers$527,533
R01 · FY2021 · AR · contact PI
VITamin D and OmegA-3 TriaL (VITAL): Interrelationship of Vitamin D and Vitamin K on Bone$648,358
R01 · FY2020 · AR · contact PI
VITamin D OmegA-3 TriaL (VITAL): Fractures, Vitamin D and Genetic Markers$587,369
R01 · FY2020 · AR · contact PI
VITamin D and OmegA-3 TriaL (VITAL): Interrelationship of Vitamin D and Vitamin K on Bone$626,331
R01 · FY2019 · AR · contact PI
VITamin D OmegA-3 TriaL (VITAL): Fractures, Vitamin D and Genetic Markers$587,369
R01 · FY2019 · AR · contact PI
VITamin D OmegA-3 TriaL (VITAL): Fractures, Vitamin D and Genetic Markers$587,369
R01 · FY2018 · AR · contact PI
VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture$285,750
R01 · FY2016 · AR · contact PI
VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture$285,750
R01 · FY2015 · AR · contact PI
VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture$280,035
R01 · FY2014 · AR · contact PI
VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture$271,463
R01 · FY2013 · AR · contact PI
Vitamin D and Omega-3 Fatty Acids(VITAL Trial): Effects on Fractures$185,318
R01 · FY2013 · AR · contact PI
VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture$285,750
R01 · FY2012 · AR · contact PI
Vitamin D and Omega-3 Fatty Acids(VITAL Trial): Effects on Fractures$195,072
R01 · FY2012 · AR · contact PI
Vitamin D and Omega-3 Fatty Acids(VITAL Trial): Effects on Fractures$195,072
R01 · FY2011 · AR · contact PI
Vitamin D and Omega-3 Fatty Acids(VITAL Trial): Effects on Fractures$203,200
R01 · FY2010 · AR · contact PI
BONE HEALTH, STRESS FRACTURES, AND VITAMIN D DEFICIENCY IN ADULTS$1,094
M01 · FY2008 · RR · contact PI
THE EFFECTS OF AGE AND VITAMIN D STATUS ON BONE$365
M01 · FY2008 · RR · contact PI
BONE HEALTH, STRESS FRACTURES, AND VITAMIN D DEFICIENCY IN ADULTS$7,334
M01 · FY2007 · RR · contact PI
THE EFFECTS OF AGE AND VITAMIN D STATUS ON BONE$2,444
M01 · FY2007 · RR · contact PI
BONE HEALTH, STRESS FRACTURES, AND VITAMIN D DEFICIENCY IN ADULTS$14,288
M01 · FY2006 · RR · contact PI
THE EFFECTS OF AGE AND VITAMIN D STATUS ON BONE$3,297
M01 · FY2006 · RR · contact PI
ZOLEDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN$2,197
M01 · FY2006 · RR · contact PI
SKELETAL HEALTH IN FEMALE ROWERS COMPARED TO RUNNERS$1,649
M01 · FY2006 · RR · contact PI
SKELETAL HEALTH IN FEMALE ROWERS COMPARED TO RUNNERS$31,706
M01 · FY2005 · RR
BONE HEALTH, STRESS FRACTURES, AND VITAMIN D DEFICIENCY IN ADULTS$3,125
M01 · FY2005 · RR
ZOLEDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN$894
M01 · FY2005 · RR
Zoledronic Acid in Treatment of Osteoporosis in Postmeno$13,583
M01 · FY2004 · RR
Skeletal Health in Female Rowers compared to Runners$3,944
M01 · FY2004 · RR
Effect of DHEA on Bone Density in Premenopausal Women$2,191
M01 · FY2004 · RR
SHORT TERM EFFECTS OF DHEA ON BONE$0
M01 · FY2002 · RR
DIABETES AND BONE METABOLISM--EFFECTS OF ORAL AGENTS$0
M01 · FY2002 · RR
PHASE II TRIAL OF CP336,156 FOR PREVENTION OF BONE LOSS IN POSTMENOPAUSAL WOMEN$0
M01 · FY2002 · RR
EFFECT OF DEHYDROEPIANDROSTERONE ON BONE DENSITY IN PREMENOPAUSAL WOMEN$0
M01 · FY2002 · RR
IDOXIFENE ON PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN$0
M01 · FY2002 · RR
MECHANISMS BY WHICH ESTROGENS AND BONE DISORDERS AFFECT BONE MASS$0
M01 · FY2002 · RR
MECHANISMS BY WHICH ESTROGENS AND BONE DISORDERS AFFECT BONE MASS$0
M01 · FY2001 · RR
DIABETES AND BONE METABOLISM--EFFECTS OF ORAL AGENTS$0
M01 · FY2001 · RR
PHASE II TRIAL OF CP336,156 FOR PREVENTION OF BONE LOSS IN POSTMENOPAUSAL WOMEN$0
M01 · FY2001 · RR
EFFECT OF DEHYDROEPIANDROSTERONE ON BONE DENSITY IN PREMENOPAUSAL WOMEN$0
M01 · FY2001 · RR
IDOXIFENE ON PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN$0
M01 · FY2001 · RR
SHORT TERM EFFECTS OF DHEA ON BONE$0
M01 · FY2001 · RR
MECHANISMS UNDERLYING THE OSTEOPENIA IN WOMEN WITH RHEUMATOID ARTHRITIS$157,130
P60 · FY2000 · AR
MECHANISMS UNDERLYING THE OSTEOPENIA IN WOMEN WITH RHEUMATOID ARTHRITIS$146,471
P60 · FY2000 · AR
MECHANISMS BY WHICH ESTROGENS AND BONE DISORDERS AFFECT BONE MASS$0
M01 · FY2000 · RR
DIABETES AND BONE METABOLISM--EFFECTS OF ORAL AGENTS$0
M01 · FY2000 · RR
PHASE II TRIAL OF CP336,156 FOR PREVENTION OF BONE LOSS IN POSTMENOPAUSAL WOMEN$0
M01 · FY2000 · RR
EFFECT OF DEHYDROEPIANDROSTERONE ON BONE DENSITY IN PREMENOPAUSAL WOMEN$0
M01 · FY2000 · RR
IDOXIFENE ON PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN$0
M01 · FY2000 · RR
SHORT TERM EFFECTS OF DHEA ON BONE$0
M01 · FY2000 · RR